相关实验视频
Updated: Jan 13, 2026
05:47
Isolation and Transplantation of Different Aged Murine Thymic Grafts.
Published on: May 13, 2015
14.5K
在低风险脏移植接受者中降低胆红蛋白剂量的有效性和安全性
1Department of Pharmacy, Cleveland Clinic Weston Hospital, Weston, Florida, USA.
Journal of transplantation
|January 7, 2026
概括
对接受脏移植的人来说,降低剂量 (3毫克/千克) 的血红蛋白与标准剂量 (4.5毫克/千克) 一样有效. 这种较低的血红蛋白剂量还通过减少白血病和感染等不良事件来提高安全性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫抑制是一种免疫抑制.
- 移植免疫学 移植免疫学
背景情况:
- 胸球蛋白是移植中的一个关键的诱导性免疫抑制剂.
- 目前的剂量缺乏标准化,导致中心间的变化.
- 对于低风险的接受者来说,实施了较低的血红蛋白剂量 (3 mg/kg).
研究的目的:
- 为了评估降低剂量 (3毫克/公斤) 与标准剂量 (4.5毫克/公斤) 的非劣质性.
- 评估低风险脏移植接受者减少胆固醇蛋白治疗方案的有效性和安全性.
主要方法:
- 单中心回顾性非劣等性队列研究.
- 包括196名低风险脏移植接受者 (2020年4月至2024年4月).
- 在接受3毫克/千克的患者和4.5毫克/千克的Thymoglobulin之间,结果的比较.
主要成果:
- 主要结局 (排斥,移植损失或6个月内死亡) 发生在减少剂量组的3%与标准剂量组的11%之间 (p=0.024).
- 3毫克/千克的胸球蛋白剂量显示出非劣质性.
- 随着3毫克/千克的剂量,人们观察到白血病,血小板减少和病毒感染的发生率有所降低.
结论:
- 对于低风险的脏移植接受者来说,3 mg/kg的胸球蛋白剂量不低于4.5 mg/kg.
- 降低的血红蛋白剂量与改善的安全结果有关.
- 这一发现支持了用于诱导免疫抑制的标准化,低剂量方法.
相关概念视频
01:28Kidney Transplant I: Introduction
333
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
333
01:26Kidney Transplant II: Surgical Procedure
298
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
298
01:16Kidney Transplant III: Nursing Management
307
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
307
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
205
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
205
01:11Renal Failure: Dose Adjustments
429
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
429
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207